The Boa system will be incorporated into the outer neoprene cap, where it provides micro-adjustability and an enhanced level of fit, function and comfort customized for each individual patient. During scalp cooling therapy, which is administered as patients undergo chemotherapy infusion, the Boa system will help to ensure complete coverage to assure consistent cooling to all areas of the scalp. Boa's single-handed adjustment makes it easy for clinicians and cappers to fine-tune the fit of the cap at any time throughout the infusion process.
"Proper fit is critical to scalp cooling success," said William Cronin, CEO of Dignitana, Inc.. "Boa is the uncontested leader in precision fit technology for wearable medical devices, and we are especially excited to announce this exclusive partnership on the eve of the one-year anniversary of our FDA clearance. Together, we are committed to giving breast cancer patients the best possible option for avoiding chemotherapy related hair loss."
The Boa system originated in 1998 in the snowboard industry to provide customized comfort and smooth, even closures in boots without pressure points. Designed to address deficiencies found in traditional snowboard boot closures, Boa innovations opened the door to improved fit and performance in multiple sport categories. Today, Boa Technology provides fit solutions across many industries, including a host of prescription orthotics and prosthetics and over-the-counter support braces. Boa's partnership with Dignitana brings it solidly into a new sector of the wearable precision medical solutions.
"We are delighted to partner with Dignitana and applaud the innovation and clinical rigor that makes them a world leader in scalp cooling therapeutics," said Bret Bostock, Global Manager for Boa Technology's Medical division. "We recognize the critical impact that this device brings to cancer patients across the country, and we are enormously pleased that our technology is being used to enhance quality of life for so many in this meaningful way."
In its first year of production, the DigniCap® system has signed contracts with 53 medical centers across 17 U.S. states. Enhanced outer caps featuring the Boa system will be available in 2017.
About Dignitana, Inc.
Headquartered in Dallas, Texas, Dignitana, Inc. is the U.S. subsidiary of Dignitana AB, a Swedish public company, based in Lund, and manufacturer of the patented medical scalp cooling device DigniCap®. Dignitana AB is listed on the OMX Nasdaq First North stock exchange and has appointed Erik Penser Bank as Certified Advisor. For more information visit www.DigniCap.com.
About Boa® Technology
With its headquarters in Denver, Colo. and offices in Austria, Hong Kong, China, and Japan, Boa® Technology Inc., is the creator of the award-winning, patented Boa system. The revolutionary Boa system, backed by the Dialed In For Life Guarantee, delivers the ultimate connection between the user and the product, transforming their experience through a fast, customizable and comfortable fit. Products powered by the Boa system can be found in the golf, snow sports, utility, safety, cycling, outdoor, medical and protective equipment categories worldwide. Visit www.BoaTechnology.com for more information.
For Dignitana, Inc.:
King + Company
1 212 561-7464 Caren.Browning@kingcompr.com
For Boa Technology:
1 206 276-8900 Casey@akimbopr.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/dignitana-partners-with-boa-technology-to-develop-the-worlds-first-precision-fit-scalp-cooling-cap-300375359.html
SOURCE Dignitana, Inc.